Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Digest.
Press releases published on May 6, 2025
Exgen Announces Investor Relations Agreement
GlobeNewswire
·
May 6, 2025
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, May 06, 2025 (GLOBE NEWSWIRE) -- ExGen Resources Inc. (TSX.V: EXG; OTC: BXXRF) (“ExGen”, the “Company”): ExGen is pleased to …
Shifting Fragrance Trends in the UAE: Big Lab Digital Agency Highlights Consumer Preferences for May 2025
EIN Presswire
·
May 6, 2025
As temperatures rise, UAE shoppers turn to lighter, fresher scents—Big Lab tracks the growing interest in summer-ready perfumes and seasonal collections. DUBAI, UNITED ARAB EMIRATES, May 6, 2025 /EINPresswire.com/ -- As temperatures rise across the UAE, …
BetterLife Announces Debt Settlements
GlobeNewswire
·
May 6, 2025
VANCOUVER, British Columbia, May 06, 2025 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development of BETR-001, a non-hallucinogenic …
FundedX Introduces 24-Hour Payout Guarantee, Fueling Record Growth in Prop Trading Sector
GlobeNewswire
·
May 6, 2025
Photo Courtesy of FundedX DUBAI, United Arab Emirates, May 06, 2025 (GLOBE NEWSWIRE) -- FundedX, a global proprietary trading firm, now guarantees 24-hour payouts for qualified traders. This operational update highlights the company's focus on efficiency …
California Resources Reports First Quarter 2025 Financial and Operating Results
GlobeNewswire
·
May 6, 2025
Returned $258 Million to Stakeholders, Maintained Balance Sheet Strength, Delivered Flat Quarter-Over-Quarter Total Net Production Company Reaffirms its 2025 Production, Capital Investment and Adjusted EBITDAX Guidance LONG BEACH, Calif., May 06, 2025 ( …
Cellectis to Report First Quarter Financial Results on May 12, 2025
GlobeNewswire
·
May 6, 2025
NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced …
Atico Produces 2.23 Million Pounds of Cu and 1,553 Ounces of Au in First Quarter 2025
GlobeNewswire
·
May 6, 2025
VANCOUVER, British Columbia, May 06, 2025 (GLOBE NEWSWIRE) -- Atico Mining Corporation (the “Company” or “Atico”) (TSX.V: ATY | OTCQX: ATCMF) announces its operating results for the three months ended March 31, 2025 from its El Roble mine. Production for …
BioAge Labs Reports First Quarter 2025 Financial Results and Provides Business Updates
GlobeNewswire
·
May 6, 2025
Advancement of lead candidate BGE-102, an oral, brain-penetrant NLRP3 inhibitor for obesity, with initial clinical data expected 2H25 New strategic collaboration with Lilly ExploR…
Leading Independent Proxy Advisory Firm ISS Recommends ACELYRIN Stockholders Vote “FOR” the Proposed Transaction with Alumis
GlobeNewswire
·
May 6, 2025
ACELYRIN Urges Stockholders to Vote FOR the Proposed Transaction Today LOS ANGELES, May 06, 2025 (GLOBE NEWSWIRE) -- ACELYRIN, INC. (Nasdaq: SLRN), a late-stage clinical biopharma company focused on accelerating the development and delivery of …
MacroGenics Announces Date of First Quarter 2025 Financial Results
GlobeNewswire
·
May 6, 2025
ROCKVILLE, MD, May 06, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today …
Supernus Announces First Quarter 2025 Financial Results
GlobeNewswire
·
May 6, 2025
First quarter 2025 net sales of Qelbree® increased 44% to $64.7 million, compared to the same period in 2024. First quarter 2025 net sales of GOCOVRI® increased 16% to $30.7 million, compared to the same period in 2024. First quarter 2025 total revenues …
Prelude Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
May 6, 2025
PRT3789 monotherapy and combination with docetaxel escalation enrollment is complete and the Company plans to present updated results in the second half of 2025 Enrollment of the Phase 1 study of Prelude’s once daily, oral SMARCA2 degrader, PRT7732 is …
Keros Therapeutics Reports Recent First Quarter 2025 Financial Results
GlobeNewswire
·
May 6, 2025
LEXINGTON, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients …
Day One Reports First Quarter 2025 Financial Results and Corporate Progress
GlobeNewswire
·
May 6, 2025
OJEMDA™ (tovorafenib) prescriptions grew 16% in Q1 2025 compared to Q4 2024 Achieved Q1 2025 OJEMDA™ (tovorafenib) net product revenue of $30.5 million Ended the first quarter with $473.0 million in cash, cash equivalents and short-term investments Company …
Acumen Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025
GlobeNewswire
·
May 6, 2025
NEWTON, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Acumen” or the “Company”), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers for the …
Late-Breaking Interim STENOVA Data Presented at Digestive Disease Week® 2025 Demonstrate Potential of AGMB-129 in Fibrostenosing Crohn’s Disease
GlobeNewswire
·
May 6, 2025
Antwerp, Belgium, May 6, 2025 – Agomab Therapeutics NV (“Agomab”) today announced late-breaking interim data from the ongoing STENOVA1 Phase 2a clinical trial for AGMB-129, an oral gastro-intestinal (GI)-restricted small molecule inhibitor of ALK5 (TGF-β …
Cosmos Health Receives Additional 180-Day Compliance Period from Nasdaq
GlobeNewswire
·
May 6, 2025
CHICAGO, May 06, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R…
Colle AI Strengthens Community Engagement Through Ongoing Platform Refinements
EIN Presswire
·
May 6, 2025
Enhanced user flows and smarter AI responsiveness help drive deeper connection between creators, collectors, and the Colle ecosystem LONDON, LONDON, UNITED KINGDOM, May 6, 2025 /EINPresswire.com/ -- Colle AI (COLLE), the multichain AI-powered NFT …
DataPatrol Showcases Latest Screen Security Innovation at GISEC 2025
EIN Presswire
·
May 6, 2025
DataPatrol showcases its latest technologies at GISEC GLOBAL 2025, the region’s leading cybersecurity event, held from May 6–8 at the Dubai World Trade Centre. DUBAI, DUBAI, UNITED ARAB EMIRATES, May 6, 2025 /EINPresswire.com/ -- DataPatrol, a …
Beacon Therapeutics Announces Positive Phase 2 Interim 6-Month Data from DAWN Trial of Laru-zova in Patients with X-linked Retinitis Pigmentosa (XLRP) at ARVO 2025
GlobeNewswire
·
May 6, 2025
Data showed improvements across several key measures of visual function, including low luminance visual acuity and microperimetry Laru-zova was generally well-tolerated by DAWN participants at 6 months LONDON and CAMBRIDGE, Mass., May 06, 2025 (GLOBE …